XML 41 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities:    
Net income $ 91,471 $ 97,117
Adjustments to reconcile net income to net cash provided by operating activities:    
Tax benefit from the exercise of stock options (1,631) (4,278)
Depreciation and amortization 10,961 9,688
Loss on disposal of fixed assets 278 885
Deferred taxes (1,120) (572)
Stock-based compensation 14,593 15,236
Deferred rent 1,035 1,420
Realized gain (loss) on sale of marketable securities 678 (136)
Loss Contingency Accrual, Period Increase (Decrease) (1,378) 0
Changes, net of acquisitions, in:    
Accounts receivable, net of allowances (1,060) (2,243)
Factor accounts receivable, net of allowances (62,079) (79,762)
Increase (Decrease) in Notes Receivable, Current 383 0
Inventories (17,075) (35,985)
Prepaids and other assets 6,965 (3,094)
Accounts payable and other accrued expenses 32,416 59,813
Net cash provided by operating activities 74,437 58,089
Cash flows from investing activities:    
Purchases of property and equipment (12,605) (16,366)
Purchases of marketable securities 17,420 50,548
Sales of marketable securities 112,293 30,146
Acquisitions, net of cash acquired (61,414) 0
Net cash provided by/(used) for investing activities 20,854 (36,768)
Cash flows from financing activities:    
Common stock repurchases for treasury (101,751) (69,465)
Proceeds from exercise of stock options 2,940 4,935
Tax benefit from the exercise of stock options 1,631 4,278
Payment of contingent liability (8,475) (7,420)
Net cash used for financing activities (105,655) (67,672)
Net decrease in cash and cash equivalents (10,364) (46,351)
Cash and cash equivalents – beginning of period 180,275 168,777
Cash and cash equivalents – end of period $ 169,911 $ 122,426